Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This research is being done to look at the association between migraine and obesity.
Research into the role of inflammatory markers and other obesity related proteins and chemicals may help us understand migraine and lead to new treatment.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Episodic migraineurs | Those with migraines >2 and < 12 times per month. | ||
| Chronic migraineurs | Those with migraines greater than 14 days per month. | ||
| Controls | Those without headaches other than occasional hangover, cold, flu headaches. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| association between migraine and obesity - evaluate serum adipokine levels | The first aim of the proposed research is to evaluate serum adipokine levels in a clinical cohort of obese and non-obese episodic and chronic migraineurs and examine their utility as markers of the presence or absence of migraine and their relationship to headache frequency. | 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| association between migraine and obesity -evaluate subcutaneous adipose tissue (SAT) and its ratio to visceral adipose tissue (VAT) | The second aim of the proposed research is to evaluate subcutaneous adipose tissue (SAT) and its ratio to visceral adipose tissue (VAT),in the same clinical cohort of migraineurs to determine if regional adipose tissue differences exist between: (1) episodic migraineurs, (2) chronic migraineurs and (3) controls, thus contributing to the migraine-obesity relationship. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Premenopausal Caucasian women ages 18-55 years with or without migraine.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Barbara L Peterlin, DO | Johns Hopkins University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Johns Hopkins Bayview Headache Center | Baltimore | Maryland | 21224 | United States |
Not provided
| ID | Term |
|---|---|
| D008881 | Migraine Disorders |
| D009765 | Obesity |
| ID | Term |
|---|---|
| D051270 | Headache Disorders, Primary |
| D020773 | Headache Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
serum
| five years |
| D009422 | Nervous System Diseases |
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |